tirzepatide and vision loss risks in patients using popular GLP-1 medications raise concerns Ozempic and vision loss: GLP-1

Avoid supplements that claim to "boost" GLP-1 without evidence, as they add cost without proven benefit

They help restore functions that may have declined due to age, stress, or other factors, giving you a path toward feeling like yourself again

NEVER take more than one compounded semaglutide injection per week

This method provides highly efficient absorption into the bloodstream and is typically administered once per week

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA as of April 2025

Gastrointestinal side effects occur systemically, regardless of injection location